tiprankstipranks
SAMSUNG PHARMACEUTICAL.CO.,Ltd. (KR:001360)
:001360
South Korea Market
001360
SAMSUNG PHARMACEUTICAL.CO.,Ltd.
RESEARCH TOOLSreports

SAMSUNG PHARMACEUTICAL.CO.,Ltd. (001360) Financial Statements

― Followers

SAMSUNG PHARMACEUTICAL.CO.,Ltd. Financial Overview

SAMSUNG PHARMACEUTICAL.CO.,Ltd.'s market cap is currently ₩129.32B. The company's EPS TTM is ₩-1451.04; its P/E ratio is -0.95; SAMSUNG PHARMACEUTICAL.CO.,Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 46.07B₩ 44.29B₩ 51.96B₩ 51.83B₩ 54.90B
Gross Profit₩ 14.64B₩ 19.77B₩ 22.97B₩ 24.62B₩ 9.28B
Operating Income₩ -19.46B₩ -14.83B₩ -18.04B₩ -13.96B₩ -19.14B
EBITDA₩ -18.06B₩ -11.74B₩ -21.69B₩ -21.97B₩ -36.46B
Net Income₩ 11.55B₩ -14.09B₩ -24.81B₩ -25.09B₩ -40.28B
Balance Sheet
Cash & Short-Term Investments₩ 16.17B₩ 10.39B₩ 4.28B₩ 55.99B₩ 64.40B
Total Assets₩ 167.44B₩ 128.45B₩ 93.48B₩ 117.91B₩ 145.46B
Total Debt₩ 17.70B₩ 5.16B₩ 595.49M₩ 2.00B₩ 2.12B
Net Debt₩ 6.53B₩ -2.23B₩ -3.69B₩ -33.99B₩ -23.98B
Total Liabilities₩ 46.39B₩ 22.60B₩ 15.89B₩ 15.32B₩ 18.19B
Stockholders' Equity₩ 121.04B₩ 105.86B₩ 77.58B₩ 102.59B₩ 127.27B
Cash Flow
Free Cash Flow₩ -10.10B₩ -17.68B₩ -40.44B₩ -4.95B₩ -11.23B
Operating Cash Flow₩ -10.05B₩ -17.30B₩ -27.66B₩ -1.91B₩ -7.16B
Investing Cash Flow₩ -12.19B₩ -22.34B₩ -2.64B₩ 12.82B₩ 18.99B
Financing Cash Flow₩ 26.02B₩ 42.72B₩ -1.42B₩ -1.00B₩ -12.21B
Currency in KRW

SAMSUNG PHARMACEUTICAL.CO.,Ltd. Earnings and Revenue History

Income Statement >

SAMSUNG PHARMACEUTICAL.CO.,Ltd. Debt to Assets

Balance Sheet >

SAMSUNG PHARMACEUTICAL.CO.,Ltd. Cash Flow

Cash Flow >

SAMSUNG PHARMACEUTICAL.CO.,Ltd. Forecast EPS vs Actual EPS

Earnings >